10 research outputs found

    The Lantern Vol. 46, No. 2, April 1980

    Get PDF
    ā€¢ The Voyage to Man\u27s Destiny ā€¢ If I Could Keep the Times ā€¢ Barstool Blues ā€¢ I Didn\u27t Know ā€¢ Felonious, Friend ā€¢ Cool Ride ā€¢ Georgia ā€¢ Let Us Eat and Drink ā€¢ In a Field ā€¢ New Born Foal ā€¢ Union to Freedom ā€¢ In the Woods ā€¢ Anthropomorphism ā€¢ Runner ā€¢ C.C. ā€¢ Lake Attempt ā€¢ A Fuzzy Blue Line ā€¢ Trust Me ā€¢ Haven\u27t We Met Before? ā€¢ Rationality ā€¢ Expecting Me ā€¢ Short Storyhttps://digitalcommons.ursinus.edu/lantern/1116/thumbnail.jp

    Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine

    Get PDF
    Despite rapid technical progress and demonstrable effectiveness for some types of diagnosis and therapy, much remains to be learned about clinical genome and exome sequencing (CGES) and its role within the practice of medicine. The Clinical Sequencing Exploratory Research (CSER) consortium includes 18 extramural research projects, one National Human Genome Research Institute (NHGRI) intramural project, and a coordinating center funded by the NHGRI and National Cancer Institute. The consortium is exploring analytic and clinical validity and utility, as well as the ethical, legal, and social implications of sequencing via multidisciplinary approaches; it has thus far recruited 5,577 participants across a spectrum of symptomatic and healthy children and adults by utilizing both germline and cancer sequencing. The CSER consortium is analyzing data and creating publically available procedures and tools related to participant preferences and consent, variant classification, disclosure and management of primary and secondary findings, health outcomes, and integration with electronic health records. Future research directions will refine measures of clinical utility of CGES in both germline and somatic testing, evaluate the use of CGES for screening in healthy individuals, explore the penetrance of pathogenic variants through extensive phenotyping, reduce discordances in public databases of genes and variants, examine social and ethnic disparities in the provision of genomics services, explore regulatory issues, and estimate the value and downstream costs of sequencing. The CSER consortium has established a shared community of research sites by using diverse approaches to pursue the evidence-based development of best practices in genomic medicine

    QCD and strongly coupled gauge theories : challenges and perspectives

    Get PDF
    We highlight the progress, current status, and open challenges of QCD-driven physics, in theory and in experiment. We discuss how the strong interaction is intimately connected to a broad sweep of physical problems, in settings ranging from astrophysics and cosmology to strongly coupled, complex systems in particle and condensed-matter physics, as well as to searches for physics beyond the Standard Model. We also discuss how success in describing the strong interaction impacts other fields, and, in turn, how such subjects can impact studies of the strong interaction. In the course of the work we offer a perspective on the many research streams which flow into and out of QCD, as well as a vision for future developments.Peer reviewe

    A Bibliography on Polish Americans, 2006ā€“2010

    No full text

    Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine

    No full text

    Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine

    No full text

    Measurements of the Total and Differential Higgs Boson Production Cross Sections Combining the H??????? and H???ZZ*???4??? Decay Channels at s\sqrt{s}=8??????TeV with the ATLAS Detector

    No full text
    Measurements of the total and differential cross sections of Higgs boson production are performed using 20.3~fbāˆ’1^{-1} of pppp collisions produced by the Large Hadron Collider at a center-of-mass energy of s=8\sqrt{s} = 8 TeV and recorded by the ATLAS detector. Cross sections are obtained from measured Hā†’Ī³Ī³H \rightarrow \gamma \gamma and Hā†’ZZāˆ—ā†’4ā„“H \rightarrow ZZ ^{*}\rightarrow 4\ell event yields, which are combined accounting for detector efficiencies, fiducial acceptances and branching fractions. Differential cross sections are reported as a function of Higgs boson transverse momentum, Higgs boson rapidity, number of jets in the event, and transverse momentum of the leading jet. The total production cross section is determined to be Ļƒppā†’H=33.0Ā±5.3ā€‰(stat)Ā±1.6ā€‰(sys)pb\sigma_{pp \to H} = 33.0 \pm 5.3 \, ({\rm stat}) \pm 1.6 \, ({\rm sys}) \mathrm{pb}. The measurements are compared to state-of-the-art predictions.Measurements of the total and differential cross sections of Higgs boson production are performed using 20.3ā€‰ā€‰fb-1 of pp collisions produced by the Large Hadron Collider at a center-of-mass energy of s=8ā€‰ā€‰TeV and recorded by the ATLAS detector. Cross sections are obtained from measured Hā†’Ī³Ī³ and Hā†’ZZ*ā†’4ā„“ event yields, which are combined accounting for detector efficiencies, fiducial acceptances, and branching fractions. Differential cross sections are reported as a function of Higgs boson transverse momentum, Higgs boson rapidity, number of jets in the event, and transverse momentum of the leading jet. The total production cross section is determined to be Ļƒppā†’H=33.0Ā±5.3ā€‰(stat)Ā±1.6ā€‰(syst)ā€‰ā€‰pb. The measurements are compared to state-of-the-art predictions.Measurements of the total and differential cross sections of Higgs boson production are performed using 20.3 fbāˆ’1^{-1} of pppp collisions produced by the Large Hadron Collider at a center-of-mass energy of s=8\sqrt{s} = 8 TeV and recorded by the ATLAS detector. Cross sections are obtained from measured Hā†’Ī³Ī³H \rightarrow \gamma \gamma and Hā†’ZZāˆ—ā†’4ā„“H \rightarrow ZZ ^{*}\rightarrow 4\ell event yields, which are combined accounting for detector efficiencies, fiducial acceptances and branching fractions. Differential cross sections are reported as a function of Higgs boson transverse momentum, Higgs boson rapidity, number of jets in the event, and transverse momentum of the leading jet. The total production cross section is determined to be Ļƒppā†’H=33.0Ā±5.3ā€‰(stat)Ā±1.6ā€‰(sys)pb\sigma_{pp \to H} = 33.0 \pm 5.3 \, ({\rm stat}) \pm 1.6 \, ({\rm sys}) \mathrm{pb}. The measurements are compared to state-of-the-art predictions
    corecore